Drug Profile
EGIS 7229
Alternative Names: S 21407Latest Information Update: 15 Aug 2007
Price :
$50
*
At a glance
- Originator Egis Pharmaceuticals; Servier
- Developer Egis Pharmaceuticals
- Class Antiarrhythmics
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias